LifeStance Health Group I...

NASDAQ: LFST · Real-Time Price · USD
5.55
0.05 (0.91%)
At close: Aug 22, 2025, 3:59 PM
5.45
-1.80%
After-hours: Aug 22, 2025, 05:06 PM EDT

LifeStance Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.32B 1.28B 1.25B 1.21B 1.16B 1.1B 1.06B 1B 959.09M 909.04M 859.54M 820.18M 776.45M 727.47M 667.51M 595.64M 523.78M 408.69M
Cost of Revenue
902.4M 884.64M 889.74M 893.2M 867.59M 821.07M 775.79M 722.95M 693.53M 656.62M 622.52M 591.6M 556.12M 515.76M 466M 409.4M 356.46M 278.4M
Gross Profit
414.08M 398.86M 361.24M 312.9M 288.67M 282.44M 279.88M 281.47M 265.56M 252.42M 237.02M 228.57M 220.33M 211.71M 201.51M 186.24M 167.32M 130.29M
Operating Income
-240K -12.86M -31.14M -64.47M -138.87M -171.72M -189.13M -202.88M -167.36M -179.42M -210.17M -279.2M -365.03M -351.6M -287.63M -168.65M -41.29M 5.86M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-21.67M -38.35M -57.61M -87.05M -159.64M -189.04M -206.58M -221.98M -186.22M -202M -232.73M -297.65M -384.65M -390.67M -333.11M -221.53M -96.7M -28.59M
Net Income
-16.15M -35.64M -57.44M -95.29M -150.92M -173.12M -186.26M -187.96M -164.23M -187.48M -215.56M -276.94M -359.54M -360.84M -307.2M -204.66M -87.5M -21.81M
Selling & General & Admin
370.78M 368.18M 362.59M 361.26M 406.94M 414.02M 409.81M 404.63M 354.94M 356.64M 375.38M 440.83M 522.52M 504.44M 433.73M 304.74M 161.33M 84.49M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
43.54M 43.54M 29.79M 15.12M 19.62M 19.6M 38.67M 57.55M 55.82M 72.58M 69.2M 65.67M 61.56M 57.59M 54.14M 38.58M 35.72M 28.37M
Operating Expenses
414.32M 411.72M 392.37M 376.38M 426.56M 453.17M 468.03M 484.35M 432.92M 431.83M 447.19M 506.5M 584.08M 562.03M 487.86M 354.88M 208.61M 124.43M
Interest Expense
20.78M 23.7M 26.54M 22.67M 22.73M 22.03M 21.22M 20.85M 19.57M 21.58M 19.93M 18.36M 17.68M 33.72M 38.91M 42.44M 45.36M 27.74M
Selling & Marketing Expenses
n/a -381K -476K -1.46M -1.46M -1.08M -983K 8.63M 8.63M 8.63M 8.63M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.32B 1.3B 1.28B 1.27B 1.29B 1.27B 1.24B 1.21B 1.13B 1.09B 1.07B 1.1B 1.14B 1.08B 953.86M 764.28M 565.07M 402.83M
Income Tax Expense
-5.52M -2.71M -170K 8.24M -8.72M -15.92M -20.32M -34.02M -21.99M -14.53M -17.17M -20.71M -25.11M -29.82M -25.91M -16.88M -9.2M -6.78M
Shares Outstanding (Basic)
385.01M 383.27M 382.74M 378.71M 379.43M 376.33M 378.73M 372.48M 363.16M 360.9M 375.96M 357.52M 353.73M 350.85M 327.52M 343.39M 313.54M 373.65M
Shares Outstanding (Diluted)
385.01M 390.67M 382.74M 378.71M 379.43M 376.33M 378.73M 372.48M 363.16M 360.9M 375.96M 357.52M 353.73M 350.85M 327.52M 343.39M 313.54M 373.65M
EPS (Basic)
-0.04 -0.09 -0.15 -0.25 -0.41 -0.48 -0.51 -0.51 -0.45 -0.51 -0.6 -0.81 -1.05 -1.08 -0.92 -0.61 -0.27 -0.06
EPS (Diluted)
-0.04 -0.09 -0.15 -0.25 -0.41 -0.48 -0.51 -0.51 -0.45 -0.51 -0.6 -0.81 -1.05 -1.08 -0.92 -0.61 -0.27 -0.06
EBITDA
56.66M 47.5M 39.87M 14.11M -53.9M -83.08M -104.93M -124.02M -91.29M -107.84M -143.6M -213.62M -305.41M -295.75M -236.46M -121.46M 3.42M 42.98M
EBIT
-888K -14.64M -31.08M -64.38M -136.9M -167.01M -185.36M -201.13M -166.66M -180.43M -212.8M -279.29M -366.97M -356.95M -294.19M -179.1M -50.7M -208K
Depreciation & Amortization
57.55M 62.14M 70.95M 78.5M 83M 83.93M 80.44M 77.11M 75.37M 72.58M 69.2M 65.67M 61.56M 57.59M 54.14M 50.15M 47.28M 39.94M